These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Free trade agreements make the drugs more expensive]. Jeppsson A Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499 [No Abstract] [Full Text] [Related]
7. [Patients, patents and profits]. Roland PC Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741 [No Abstract] [Full Text] [Related]
8. Statin utilisation--recognising the role of the invisible hand. Minhas R Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171 [No Abstract] [Full Text] [Related]
10. [The patent is "engine" in drug development]. Bergström R Lakartidningen; 2008 Mar 5-11; 105(10):752. PubMed ID: 18422246 [No Abstract] [Full Text] [Related]
11. [Discount for only one drug of the same group leads to impaired health care quality]. Bergström R Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044 [No Abstract] [Full Text] [Related]
12. White paper. The five myths of generic competition. A Pharma Matters report. March 2009. Drug News Perspect; 2009 Apr; 22(3):171-5. PubMed ID: 19440560 [TBL] [Abstract][Full Text] [Related]
13. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
14. [What drug companies actually do]. Tonby K Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1806. PubMed ID: 17599137 [No Abstract] [Full Text] [Related]
15. Handle with care. Macilwain C Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170 [No Abstract] [Full Text] [Related]
17. Market watch: Sales of biologics to show robust growth through to 2013. Goodman M Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035 [No Abstract] [Full Text] [Related]
18. Supreme Court rules against drug patent "evergreening". Kondro W CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081 [No Abstract] [Full Text] [Related]
19. India's new patent bill threatens generic industry. Ahmad K Lancet Infect Dis; 2005 May; 5(5):265. PubMed ID: 15889471 [No Abstract] [Full Text] [Related]
20. Are patent expirations the answer to improving patient adherence? Klepser DG Am J Manag Care; 2008 Dec; 14(12):787-8. PubMed ID: 19067495 [No Abstract] [Full Text] [Related] [Next] [New Search]